Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCIF

Healthcare Biotechnology
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol... see more

Current News (TSX:CSCI)

COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore

GlobeNewswire December 1, 2025

COSCIENS Biopharma Inc. Announces Leadership Change

GlobeNewswire November 14, 2025

COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update

GlobeNewswire November 11, 2025

COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update

GlobeNewswire August 14, 2025

COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

GlobeNewswire June 30, 2025

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders

GlobeNewswire May 30, 2025

COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders

GlobeNewswire May 26, 2025

Goodwood to Nominate New Directors for COSCIENS Biopharma Inc.

Canada NewsWire May 23, 2025

COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire May 13, 2025
View More News ››

Opinion & Analysis (TSX:CSCI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:CSCI)

RE:RE:New Press Release - COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore

To keep exclusitivty Wuzhou should have to make minimum volumes each year.
lscfa - December 2, 2025

RE:New Press Release - COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore

The agreement is for an initial ten-year term and includes a commitment by Wuzhou for a minimum initial order of approximately €800,000. ...
archeo753 - December 2, 2025

RE:RE:Good Overview

Let see, in the last 15 weeks or so, q2 results, then q3 results and the announcement that Anne was shown was give the punt, Great...
Hopeforthebest - November 29, 2025

RE:Good Overview

"Peter Puccetti is already actively involved in defining and executing the company’s strategic direction, particularly in areas of...
Apostata - November 27, 2025

RE:Good Overview

Thanks Archeo, excellent find. Hopefully we finally have a competent CEO that knows that shareholder value means just that and not lining...
Hopeforthebest - November 25, 2025

Good Overview

https://business-news-today.com/from-boardroom-to-executive-seat-puccetti-steps-in-as-cosciens-biopharma-interim-chief/ Will this lead...
archeo753 - November 25, 2025
View more Bullboard ››

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation

View More »

Podcasts